34 research outputs found

    Overview of the JET results in support to ITER

    Get PDF

    Role of radiotherapy in Hodgkin’s lymphoma

    No full text
    Radiotherapy is a well-established element in the treatment of Hodgkin's lymphoma. An analysis of the literature in the database PubMed on the development and importance of radiotherapy within the framework of treatment of Hodgkin's lymphoma was performed. Over the last century radiotherapy has been shown to be the most effective single modality in the treatment of Hodgkin's lymphoma. In the beginning extended field radiotherapy (EF-RT) was commonly used and induced remission rates of 90 % in early stage Hodgkin's lymphoma. However, further improvement of freedom from treatment failure (FFTF) could only be achieved through the addition of polychemotherapy. This multimodal treatment concept has been rigorously tested over many generations in clinical trials leading to continuous reduction in the radiation dose and target volume with the same or better efficiency. More recent studies focused on reducing therapy-associated side effects especially in young patients who have an excellent long-term prognosis, by attempting to stratify treatment with possible reduction in therapy intensity. In the era of personalized medicine, treatment regimes will focus on targeted systemic therapy but will still rely on highly effective consolidating radiotherapy (combined modality)

    BEACOPP (escalated)

    No full text

    Treatment of Merkel Cell Carcinoma

    No full text
    corecore